BRPI0710959B8 - uso de uma proteína anti-secretória ou fragmentos da mesma para a fabricação de uma composição farmacêutica para a prevenção ou tratamento da hipertensão intra-ocular. - Google Patents
uso de uma proteína anti-secretória ou fragmentos da mesma para a fabricação de uma composição farmacêutica para a prevenção ou tratamento da hipertensão intra-ocular.Info
- Publication number
- BRPI0710959B8 BRPI0710959B8 BRPI0710959A BRPI0710959A BRPI0710959B8 BR PI0710959 B8 BRPI0710959 B8 BR PI0710959B8 BR PI0710959 A BRPI0710959 A BR PI0710959A BR PI0710959 A BRPI0710959 A BR PI0710959A BR PI0710959 B8 BRPI0710959 B8 BR PI0710959B8
- Authority
- BR
- Brazil
- Prior art keywords
- prevention
- treatment
- secretory
- fragments
- manufacture
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/12—Aerosols; Foams
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- General Chemical & Material Sciences (AREA)
- Ophthalmology & Optometry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Marine Sciences & Fisheries (AREA)
- Zoology (AREA)
- Dispersion Chemistry (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Peptides Or Proteins (AREA)
Abstract
uso de uma proteína anti-secretória e peptídeo. a presente invenção refere-se ao uso de fatores anti-secretórios, tal como proteínas anti-secretórias, ou homólogos, derivados e/ou fragmentos da mesma com atividade anti-secretória, para a fabricação de composições farmacêuticas para o uso no tratamento e/ou prevenção da hipertensão intra-ocular. a invenção refere-se, portanto, ao uso de composições farmacêuticas contendo fatores anti-secretórios na prevenção e/ou tratamento da hipertensão intra-ocular, a qual se caracteriza principalmente pela obstrução do efluxo de fluido corporal, resultando na elevação da pressão no olho. a invenção se presta a uma nova abordagem para o tratamento e/ou prevenção de tal condição, reduzindo a pressão a níveis aceitáveis, opcionalmente de 21 mm hg ou menos.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE0600932-8 | 2006-04-27 | ||
| SE0600932 | 2006-04-27 | ||
| PCT/SE2007/000414 WO2007126364A2 (en) | 2006-04-27 | 2007-04-27 | Use of antisecretory factors for treating intraocular hypertension |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| BRPI0710959A2 BRPI0710959A2 (pt) | 2012-02-28 |
| BRPI0710959B1 BRPI0710959B1 (pt) | 2018-11-06 |
| BRPI0710959B8 true BRPI0710959B8 (pt) | 2021-05-25 |
Family
ID=38561776
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI0710959A BRPI0710959B8 (pt) | 2006-04-27 | 2007-04-27 | uso de uma proteína anti-secretória ou fragmentos da mesma para a fabricação de uma composição farmacêutica para a prevenção ou tratamento da hipertensão intra-ocular. |
Country Status (18)
| Country | Link |
|---|---|
| US (2) | US8207296B2 (pt) |
| EP (2) | EP2015767B1 (pt) |
| JP (2) | JP5284948B2 (pt) |
| KR (1) | KR20090040404A (pt) |
| CN (2) | CN101432013B (pt) |
| AU (1) | AU2007244004B2 (pt) |
| BR (1) | BRPI0710959B8 (pt) |
| CA (2) | CA2771087C (pt) |
| DK (2) | DK2468292T3 (pt) |
| ES (2) | ES2561945T3 (pt) |
| IL (1) | IL194773A (pt) |
| MX (1) | MX2008013769A (pt) |
| NZ (2) | NZ598426A (pt) |
| PL (2) | PL2015767T3 (pt) |
| RU (1) | RU2458703C2 (pt) |
| SG (1) | SG171602A1 (pt) |
| WO (1) | WO2007126364A2 (pt) |
| ZA (1) | ZA200809115B (pt) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2561945T3 (es) * | 2006-04-27 | 2016-03-01 | Lantmannen As-Faktor Ab | Uso de un factor antisecretor para tratar la hipertensión intraocular |
| US9962424B2 (en) | 2007-04-27 | 2018-05-08 | Lantmännen As-Faktor Ab | Use of antisecretory factors (AF) for optimizing cellular uptake |
| JP5820277B2 (ja) | 2009-02-11 | 2015-11-24 | ラントメネン・アーエス−ファクトール・アーベー | 細胞取込を最適化するための抗分泌性因子（ａｆ）の使用 |
| WO2013050795A1 (en) * | 2011-10-03 | 2013-04-11 | Femtonics Kft. | Use of photoactive compounds |
| EP2934564B1 (en) * | 2012-12-20 | 2018-05-23 | Lantmännen AS-Faktor AB | Antisecretory factor (af) for use in the treatment of glioblastoma |
| RU2723097C1 (ru) | 2015-07-10 | 2020-06-08 | Лантменнен Ас-Фактор Аб | Способ получения яичного желтка с высоким содержанием af-16 |
| EP3484909B1 (en) | 2016-07-18 | 2021-06-16 | Lantmännen Medical AB | Antisecretory factor 17 |
| CA3103164A1 (en) | 2018-06-28 | 2020-01-02 | Lantmannen Medical Ab | Antisecretory factor for use in treatment and/or prevention of acute respiratory failure |
| WO2020065089A2 (en) | 2018-09-28 | 2020-04-02 | Lantmännen Functional Foods Ab | A consumable product comprising malted dehulled oat |
| WO2020065091A1 (en) | 2018-09-28 | 2020-04-02 | Lantmännen Functional Foods Ab | A consumable product comprising malted wheat |
| WO2021191431A1 (en) | 2020-03-26 | 2021-09-30 | Lantmännen Functional Foods Ab | A consumable product comprising malted cereals for promoting recovery at physical activity |
| WO2024102346A1 (en) * | 2022-11-08 | 2024-05-16 | Aisa Pharma, Inc. | Methods of treating eye pain and eye disorders |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CH682716A5 (de) | 1992-01-13 | 1993-11-15 | Christian Fricker | Benzo-Pyrone und/oder Dobesilat-Calcium enthaltende pharmazeutische Zusammensetzung. |
| US5585401A (en) * | 1994-12-09 | 1996-12-17 | The Reents Of The University Of California | Method for enhancing outflow of aqueous humor in treatment of glaucoma |
| SE508609C2 (sv) | 1995-08-24 | 1998-10-19 | Rural Patent Svenska Ab | Antisekretorisk faktor - dess aminosyrasekvens, nubleinsyrasekvens och användning |
| JP2000506375A (ja) * | 1996-01-26 | 2000-05-30 | エイチエスシー リサーチ アンド デベロップメント リミテッド パートナーシップ | アルツハイマー病に関連する核酸およびタンパク質、ならびにその使用 |
| SE506486C2 (sv) * | 1996-11-20 | 1997-12-22 | Svenska Lantmaennen Riksfoerbu | Födoämne som vid förtäring inducerar antisekretoriska proteiner |
| SE513496C2 (sv) * | 1998-12-17 | 2000-09-18 | Rural Patent Svenska Ab | NASP-berikad äggula samt dess användning |
| JP2004513066A (ja) * | 1999-06-21 | 2004-04-30 | インカイン ファーマシューティカル カンパニー，インコーポレイティド | アンジオシジン：ｃｙｓ−ｓｅｒ−ｖａｌ−ｔｈｒ−ｃｙｓ−ｇｌｙ特異的腫瘍細胞付着受容体 |
| RU2192898C1 (ru) * | 2001-08-16 | 2002-11-20 | Московский научно-исследовательский институт глазных болезней им. Гельмгольца | Способ лечения герпетического кератита с изъязвлением |
| GB0322645D0 (en) * | 2003-09-26 | 2003-10-29 | Melacure Therapeutics Ab | Use of antisecretory factor peptides |
| ES2561945T3 (es) * | 2006-04-27 | 2016-03-01 | Lantmannen As-Faktor Ab | Uso de un factor antisecretor para tratar la hipertensión intraocular |
| CA2650132C (en) * | 2006-04-27 | 2017-10-24 | Hans-Arne Hansson | Modulation of lipid rafts |
| DK2037950T3 (da) * | 2006-04-27 | 2014-06-30 | Lantmännen As Faktor Ab | Yderligere medicinske anvendelser af antisekretorisk protein |
-
2007
- 2007-04-27 ES ES07748079.6T patent/ES2561945T3/es active Active
- 2007-04-27 EP EP07748079.6A patent/EP2015767B1/en not_active Not-in-force
- 2007-04-27 NZ NZ598426A patent/NZ598426A/xx not_active IP Right Cessation
- 2007-04-27 ES ES12157100T patent/ES2773945T3/es active Active
- 2007-04-27 EP EP12157100.4A patent/EP2468292B8/en active Active
- 2007-04-27 CA CA2771087A patent/CA2771087C/en not_active Expired - Fee Related
- 2007-04-27 NZ NZ572255A patent/NZ572255A/en not_active IP Right Cessation
- 2007-04-27 KR KR1020087029053A patent/KR20090040404A/ko active Search and Examination
- 2007-04-27 PL PL07748079T patent/PL2015767T3/pl unknown
- 2007-04-27 BR BRPI0710959A patent/BRPI0710959B8/pt not_active IP Right Cessation
- 2007-04-27 CN CN200780014996.XA patent/CN101432013B/zh not_active Expired - Fee Related
- 2007-04-27 AU AU2007244004A patent/AU2007244004B2/en not_active Ceased
- 2007-04-27 PL PL12157100T patent/PL2468292T3/pl unknown
- 2007-04-27 WO PCT/SE2007/000414 patent/WO2007126364A2/en active Application Filing
- 2007-04-27 DK DK12157100.4T patent/DK2468292T3/da active
- 2007-04-27 SG SG201102876-8A patent/SG171602A1/en unknown
- 2007-04-27 CA CA2650344A patent/CA2650344C/en not_active Expired - Fee Related
- 2007-04-27 MX MX2008013769A patent/MX2008013769A/es active IP Right Grant
- 2007-04-27 CN CN201210058790.XA patent/CN102633863B/zh not_active Expired - Fee Related
- 2007-04-27 DK DK07748079.6T patent/DK2015767T3/en active
- 2007-04-27 JP JP2009507632A patent/JP5284948B2/ja not_active Expired - Fee Related
- 2007-04-27 RU RU2008146733/15A patent/RU2458703C2/ru active
-
2008
- 2008-10-22 IL IL194773A patent/IL194773A/en active IP Right Grant
- 2008-10-23 ZA ZA200809115A patent/ZA200809115B/xx unknown
- 2008-10-27 US US12/289,388 patent/US8207296B2/en not_active Expired - Fee Related
-
2012
- 2012-03-05 JP JP2012047547A patent/JP2012153695A/ja active Pending
- 2012-05-11 US US13/469,838 patent/US9000125B2/en not_active Expired - Fee Related
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BRPI0710959B8 (pt) | uso de uma proteína anti-secretória ou fragmentos da mesma para a fabricação de uma composição farmacêutica para a prevenção ou tratamento da hipertensão intra-ocular. | |
| BRPI0519508A2 (pt) | análogos de aminopirazina para tratamento de glaucoma e outras doenças ou condições mediadas por rho cinase | |
| BRPI0607447A2 (pt) | solução oftálmica de bimatoprost aprimorada | |
| WO2007104541A3 (en) | Compositions and methods using serine protease inhibiting peptides for treating ophthalmic disorders | |
| GEP20084520B (en) | Use of retinyl derivatives and compositions thereof for treating ophthalmic diseases | |
| WO2007054257A3 (en) | Indene derivatives, their preparation and use as medicaments | |
| MX2010007295A (es) | Composiciones acuosas estables de ciclosporina. | |
| BRPI0408690A (pt) | composto, método para tratamento de uma doença, composição farmacêutica, e, uso de um composto | |
| WO2007016538A3 (en) | Preparation and use of biphenyl amino acid derivatives for the treatment of obesity | |
| EA200800655A1 (ru) | Производные азабициклогексана | |
| WO2006044425A3 (en) | Ophthalmic compositions for treating ocular hypertension | |
| BRPI0412893A (pt) | composto, composição farmacêutica, uso de um composto, e, métodos de prevenção, tratamento ou melhora de doenças ou condições inflamatórias, ou doenças ou condições oftálmicas, de tratamento ou melhora de cáncer e para a produção de um composto | |
| BR112012015188A8 (pt) | composição e método para o tratamento e/ou a prevenção de uma doença ocular relacionada à angiogênese | |
| MX2013007067A (es) | Anticuerpos anti-il-18 y sus usos. | |
| EA200870396A1 (ru) | Лечение аллергических заболеваний глаз | |
| MY149505A (en) | Hyaluronic acid binary mixtures and therapeutic use thereof | |
| BRPI0417833A (pt) | novos derivados de benzofurano, os quais podem ser usados na profilaxia ou tratamento de distúrbios relacionados com o receptor 5-ht6 | |
| WO2008041133A3 (en) | Use of chlorine guanabenz derivatives for treating polyglutamine expansion associated diseases | |
| CA2866232A1 (en) | Aqueous pharmaceutical composition containing a biologic therapeutic agent and guanidine or a guanidine derivative and an injection including the composition | |
| MY146920A (en) | Aminothiazole derivatives and their uses as antibacterial agents | |
| BR0210238A (pt) | Novos análogos de aril-amino-propano e seu uso para o tratamento de glaucoma | |
| WO2006074452A3 (en) | Regulation of ccn2 by ccn3 and its therapeutic and diagnostic potential in fibrosis, sclerosis and other diseases | |
| WO2004043354A3 (en) | Ophthalmic compositions for treating ocular hypertension | |
| WO2008152068A3 (en) | [1,10]-phenanthroline derivatives for the treatment of neurodegenerative or haematological diseases | |
| JP2018507259A (ja) | 抗微生物ペプチド |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
| B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] | ||
| B06A | Patent application procedure suspended [chapter 6.1 patent gazette] | ||
| B06A | Patent application procedure suspended [chapter 6.1 patent gazette] | ||
| B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
| B16A | Patent or certificate of addition of invention granted [chapter 16.1 patent gazette] |
Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 06/11/2018, OBSERVADAS AS CONDICOES LEGAIS. |
|
| B16C | Correction of notification of the grant [chapter 16.3 patent gazette] |
Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 27/04/2007 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF |
|
| B21F | Lapse acc. art. 78, item iv - on non-payment of the annual fees in time |
Free format text: REFERENTE A 15A ANUIDADE. |
|
| B24J | Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12) |
Free format text: EM VIRTUDE DA EXTINCAO PUBLICADA NA RPI 2668 DE 22-02-2022 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDA A EXTINCAO DA PATENTE E SEUS CERTIFICADOS, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |